- Home
- REPL vs ISD Comparison
REPL vs ISD Comparison
Compare REPL & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- ISD
- Stock Information
- Founded
- REPL 2015
- ISD 2012
- Country
- REPL United States
- ISD United States
- Employees
- REPL N/A
- ISD N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- ISD Trusts Except Educational Religious and Charitable
- Sector
- REPL Health Care
- ISD Finance
- Exchange
- REPL Nasdaq
- ISD Nasdaq
- Market Cap
- REPL 547.0M
- ISD 472.3M
- IPO Year
- REPL 2018
- ISD N/A
- Fundamental
- Price
- REPL $9.42
- ISD $14.36
- Analyst Decision
- REPL Buy
- ISD
- Analyst Count
- REPL 9
- ISD 0
- Target Price
- REPL $12.00
- ISD N/A
- AVG Volume (30 Days)
- REPL 2.6M
- ISD 127.1K
- Earning Date
- REPL 11-06-2025
- ISD 01-01-0001
- Dividend Yield
- REPL N/A
- ISD 9.69%
- EPS Growth
- REPL N/A
- ISD N/A
- EPS
- REPL N/A
- ISD N/A
- Revenue
- REPL N/A
- ISD N/A
- Revenue This Year
- REPL N/A
- ISD N/A
- Revenue Next Year
- REPL N/A
- ISD N/A
- P/E Ratio
- REPL N/A
- ISD N/A
- Revenue Growth
- REPL N/A
- ISD N/A
- 52 Week Low
- REPL $2.68
- ISD $10.98
- 52 Week High
- REPL $17.00
- ISD $13.17
- Technical
- Relative Strength Index (RSI)
- REPL 62.38
- ISD 46.02
- Support Level
- REPL $8.50
- ISD $14.24
- Resistance Level
- REPL $9.30
- ISD $14.49
- Average True Range (ATR)
- REPL 0.61
- ISD 0.12
- MACD
- REPL -0.14
- ISD -0.02
- Stochastic Oscillator
- REPL 75.95
- ISD 33.33
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.